JP2009507073A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009507073A5 JP2009507073A5 JP2008530093A JP2008530093A JP2009507073A5 JP 2009507073 A5 JP2009507073 A5 JP 2009507073A5 JP 2008530093 A JP2008530093 A JP 2008530093A JP 2008530093 A JP2008530093 A JP 2008530093A JP 2009507073 A5 JP2009507073 A5 JP 2009507073A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- aryl
- group
- heterocycloalkyl
- alkylheterocycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71464505P | 2005-09-07 | 2005-09-07 | |
| EP05109450 | 2005-10-11 | ||
| PCT/US2006/033686 WO2007030362A1 (en) | 2005-09-07 | 2006-08-28 | Ikk inhibitors for the treatment of endometriosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009507073A JP2009507073A (ja) | 2009-02-19 |
| JP2009507073A5 true JP2009507073A5 (https=) | 2009-10-15 |
Family
ID=37663766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008530093A Pending JP2009507073A (ja) | 2005-09-07 | 2006-08-28 | 子宮内膜症の治療のためのｉｋｋ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100069387A1 (https=) |
| EP (2) | EP1931322B1 (https=) |
| JP (1) | JP2009507073A (https=) |
| KR (1) | KR20080052650A (https=) |
| CN (1) | CN101304736A (https=) |
| AU (1) | AU2006287767B2 (https=) |
| CA (1) | CA2621057A1 (https=) |
| EA (1) | EA200800755A1 (https=) |
| IL (1) | IL189659A0 (https=) |
| WO (1) | WO2007030362A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010009166A1 (en) | 2008-07-14 | 2010-01-21 | Gilead Colorado, Inc. | Oxindolyl inhibitor compounds |
| US8124764B2 (en) | 2008-07-14 | 2012-02-28 | Gilead Sciences, Inc. | Fused heterocyclyc inhibitor compounds |
| CA2729909A1 (en) | 2008-07-14 | 2010-01-21 | Gilead Sciences, Inc. | Imidazolyl pyrimidine inhibitor compounds |
| CN102123987A (zh) | 2008-07-28 | 2011-07-13 | 吉里德科学公司 | 亚环烷基和亚杂环烷基组蛋白脱乙酰酶抑制剂化合物 |
| CN101503402B (zh) * | 2009-03-10 | 2014-06-25 | 沈阳药科大学 | 2-苯胺嘧啶衍生物及其制备和用途 |
| US8283357B2 (en) | 2009-06-08 | 2012-10-09 | Gilead Sciences, Inc. | Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds |
| KR20120031170A (ko) | 2009-06-08 | 2012-03-30 | 길리애드 사이언시즈, 인코포레이티드 | 알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물 |
| CA2767914C (en) | 2009-07-24 | 2020-02-25 | Geadic Biotec, Aie. | Markers for endometrial cancer |
| ES2577829T3 (es) | 2010-06-04 | 2016-07-19 | F. Hoffmann-La Roche Ag | Derivados de aminopirimidina como moduladores de la LRRK2 |
| NO2638031T3 (https=) | 2010-11-10 | 2018-03-10 | ||
| US10729693B2 (en) | 2018-03-02 | 2020-08-04 | Ponce Medical School Foundation, Inc. | Compositions and methods for the treatment of endometriosis |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| US11384083B2 (en) | 2019-02-15 | 2022-07-12 | Incyte Corporation | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors |
| TW202100520A (zh) | 2019-03-05 | 2021-01-01 | 美商英塞特公司 | 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物 |
| WO2020205560A1 (en) | 2019-03-29 | 2020-10-08 | Incyte Corporation | Sulfonylamide compounds as cdk2 inhibitors |
| WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
| US11447494B2 (en) | 2019-05-01 | 2022-09-20 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| CA3150681A1 (en) | 2019-08-14 | 2021-02-18 | Incyte Corporation | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors |
| US11851426B2 (en) | 2019-10-11 | 2023-12-26 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
| CN119769990B (zh) * | 2024-12-26 | 2025-09-09 | 大连医科大学附属第二医院 | 子宫内膜异位症的检测系统和治疗剂 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0160699B1 (en) | 1983-11-02 | 1992-08-12 | Applied Research Systems Ars Holding N.V. | Production of heterodimeric human fertlity hormones |
| US4923805A (en) | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh |
| IT1206302B (it) | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
| JP2002193938A (ja) * | 2000-12-01 | 2002-07-10 | Bayer Ag | ４−アリールピリジン誘導体 |
| US7122544B2 (en) * | 2000-12-06 | 2006-10-17 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| US20030134836A1 (en) * | 2001-01-12 | 2003-07-17 | Amgen Inc. | Substituted arylamine derivatives and methods of use |
| PL364111A1 (en) * | 2001-02-01 | 2004-12-13 | Bristol-Myers Squibb Company | Methods of treating inflammatory and immune diseases using inhibitors of ikappab kinase (ikk) |
| SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| ATE498408T1 (de) * | 2001-08-10 | 2011-03-15 | Takeda Pharmaceutical | Gnrh-agonistische kombinationsmittel |
| DE10237722A1 (de) | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
| JP2006508997A (ja) * | 2002-11-28 | 2006-03-16 | シエーリング アクチエンゲゼルシャフト | Ｃｈｋ−、Ｐｄｋ−およびＡｋｔ−阻害性ピリミジン、それらの製造および薬剤としての使用 |
| EP1670908A2 (en) * | 2003-10-02 | 2006-06-21 | Xantos Biomedicine AG | Medical use of tbk-1 or of inhibitors thereof |
-
2006
- 2006-08-28 AU AU2006287767A patent/AU2006287767B2/en not_active Ceased
- 2006-08-28 EP EP06813899A patent/EP1931322B1/en active Active
- 2006-08-28 WO PCT/US2006/033686 patent/WO2007030362A1/en not_active Ceased
- 2006-08-28 EA EA200800755A patent/EA200800755A1/ru unknown
- 2006-08-28 US US11/991,578 patent/US20100069387A1/en not_active Abandoned
- 2006-08-28 CN CNA2006800414833A patent/CN101304736A/zh active Pending
- 2006-08-28 EP EP10184024A patent/EP2266561A3/en not_active Withdrawn
- 2006-08-28 KR KR1020087008180A patent/KR20080052650A/ko not_active Ceased
- 2006-08-28 JP JP2008530093A patent/JP2009507073A/ja active Pending
- 2006-08-28 CA CA002621057A patent/CA2621057A1/en not_active Abandoned
-
2008
- 2008-02-21 IL IL189659A patent/IL189659A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009507073A5 (https=) | ||
| JP6193922B2 (ja) | ハロアルキルヘテロアリールベンズアミド化合物 | |
| CA3027563C (en) | AR+ METHODS FOR BREAST CANCER TREATMENT | |
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| JP2007519649A5 (https=) | ||
| AU2013215251A1 (en) | Combination of a RTK inhibitor with an anti - estrogen and use thereof for the treatment of cancer | |
| AU2006287767B2 (en) | IKK inhibitors for the treatment of endometriosis | |
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| JP2016512558A5 (https=) | ||
| JP2012510989A5 (https=) | ||
| JP2010513448A5 (https=) | ||
| CN103052388A (zh) | σ配体在阿片类药物诱导的痛觉过敏中的应用 | |
| CA2526908A1 (en) | Combination of histone deacetylase inhibitors with chemotherapeutic agents | |
| CA2669128A1 (en) | Treatment for multiple myeloma | |
| AR068947A1 (es) | Inhibidor de la proteina activadora de la 5- lipoxigenasa (flap), composiciones farmaceuticas, sales y solvatos | |
| JP2012515787A5 (https=) | ||
| CZ321094A3 (en) | Pharmaceutical preparation for inhibiting non-functional uterus bleeding | |
| KR20020090153A (ko) | 알콜중독 또는 알콜 의존을 위한 배합 치료 | |
| JP2009501745A5 (https=) | ||
| JP2019182865A5 (https=) | ||
| JP2016027024A5 (https=) | ||
| RU2016133285A (ru) | Фармацевтические комбинации | |
| JP2015502386A5 (https=) | ||
| JP2017502989A5 (https=) | ||
| WO2013009812A1 (en) | Methods of treatment |